Balasa Dinverno & Foltz LLC Pfizer Inc Transaction History

Balasa Dinverno & Foltz LLC

$1.58 Billion
Q3 2022

A detailed history of Balasa Dinverno & Foltz LLC transactions in Pfizer Inc stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 84,074 shares of PFE stock, worth $2.25 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

84,074

Previous 84,781 0.83%

Holding current value

$2.25 Million

Previous $4.45 Million 17.23%

% of portfolio

0.23%

Previous 0.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	SELL	$43.76 - $53.42 $30,938 - $37,767	-707 Reduced 0.83%	84,074 $3.68 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $227,299 - $269,505	-4,885 Reduced 5.45%	84,781 $4.45 Million
Q1 2022 Apr 25, 2022	BUY	$45.75 - $56.69 $501,557 - $621,492	10,963 Added 13.93%	89,666 $4.64 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $63,054 - $93,467	-1,526 Reduced 1.9%	78,703 $4.65 Million
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $370,755 - $476,267	9,446 Added 13.35%	80,229 $3.45 Million
Q2 2021 Jul 23, 2021	BUY	$35.91 - $40.68 $545,796 - $618,295	15,199 Added 27.34%	70,783 $2.77 Million
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $99,364 - $112,063	-2,967 Reduced 5.07%	55,584 $2.01 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $185,725 - $236,165	5,549 Added 10.47%	58,551 $2.16 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $574,706 - $674,262	18,101 Added 51.86%	53,002 $1.95 Million
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $90,239 - $109,473	2,996 Added 9.39%	34,901 $1.14 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $136,663 - $195,262	-5,056 Reduced 13.68%	31,905 $1.04 Million
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $441,918 - $501,520	-13,424 Reduced 26.64%	36,961 $1.45 Million
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $479,747 - $622,091	-14,766 Reduced 22.66%	50,385 $1.81 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $281,343 - $315,884	-7,608 Reduced 10.46%	65,151 $2.82 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $170,962 - $187,830	-4,559 Reduced 5.9%	72,759 $3.09 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $396,279 - $451,801	10,301 Added 15.37%	77,318 $3.38 Million
Q3 2018 Oct 24, 2018	BUY	$34.47 - $41.81 $148,669 - $180,326	4,313 Added 6.88%	67,017 $2.95 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $478,012 - $509,609	14,494 Added 30.06%	62,704 $2.28 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $119,343 - $138,454	3,740 Added 8.41%	48,210 $1.71 Million
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $153,594 - $162,969	4,618 Added 11.59%	44,470 $1.61 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $1.24 Million - $1.36 Million	39,852	39,852 $1.42 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.

Account

Balasa Dinverno & Foltz LLC Pfizer Inc Transaction History